More than 600 health care and construction workers donned pink hard hats while forming a giant human ribbon at the UC San Diego Jacobs Medical Center construction site today in support of National Breast Cancer Awareness month.
Researchers at the University of California, San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease. The goal of the study is to determine whether the drug can slow the progression of the disease by keeping the brain’s dopamine-producing cells healthier for a longer period of time.
The University of California, San Diego will host a robotics forum on October 10, 2014. The eight headlining speakers are world leaders in robotics disciplines that are relevant for the coming era of ubiquitous consumer robotics. Medicine, agriculture, environmental monitoring and disaster response are some of the areas of modern society that ubiquitous consumer robotics is poised to disrupt.
Four teams of scientists at UC San Diego will receive research grants from the National Institutes of Health that will help lay the groundwork for visualizing the circuits of the brain and how they work, the agency announced at a White House ceremony today.
Researchers have found that a key neuronal protein called alpha-synuclein normally gathers in synapses, where aggregates of it help regulate neurotransmissions. In overabundance, though, a-synuclein can choke off communication altogether, leading to neuronal death and related diseases.
Chemical fingerprints of the element nitrogen vary by extremes in materials from the molecules of life to the solar wind to interstellar dust. Ideas for how this great variety came about have included alien molecules shuttled in by icy comets from beyond our solar system and complex chemical scenarios.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
